Sector: Pharmaceuticals & Biotechnology

Small Cap

Bafna Pharma Share Price

Bafna Pharmaceuticals Ltd.

₹174.58

-19.39(-10.00%)

Trade Now

9th Jun 2026 | 3:28 PM

NSE : BAFNAPH

Open Free Demat Account

Bafna Pharma Performance

Price Movement

₹174.58

₹213.36

↘ Today's Low↗ Today's High

1 Year Performance

₹174.58

₹72.01

₹202.06

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹213.36

Low₹174.58

Open at₹209.70

Prev Close₹193.97

Volumes2.84 L

Avg Price₹195.77

Lower Circuit₹174.58

Upper Circuit₹213.36

Historical Performance

3M High₹213.36

3M Low₹94.77

1 Yr High₹213.36

1 Yr Low₹72.01

3 Yr High₹213.36

3 Yr Low₹69.00

5 Yr High₹213.36

5 Yr Low₹69.00

Summary

As of 09-06-2026 23:17, Bafna Pharmaceuticals Ltd. share price today is ₹0, with a change of ₹-193.97 (-100.00%) from the previous close of ₹193.97. The stock opened at ₹209.7 and traded between ₹174.58 and ₹213.36, with a total traded volume of 283731 shares. The company has a market capitalization of ₹413 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹202.06 and ₹72.01, respectively.

Bafna Pharmaceuticals Ltd. valuation metrics include a P/E ratio of 37.2, and book value of ₹4.40. Profitability indicators show ROE of 11.54%. Bafna Pharmaceuticals Ltd. has reported revenue of ₹150.62 Cr and net profit of ₹11.1 Cr.

Bafna Pharmaceuticals Ltd. technical indicators include Day RSI at 85.81, Day MFI at 82.56, Day ADX at 26.26. Additional indicators include Commodity Channel Index (CCI) at 297.8. Momentum indicators show Day MACD at 10.31, Day MACD Signal Line at 4.87, DayATR at 8.54. Rate of Change indicators for Bafna Pharmaceuticals Ltd. include ROC125 at 28.3 and ROC21 at 47.82.

Exponential moving averages include EMA5 at ₹169.9, EMA10 at ₹157.3, EMA12 at ₹154.4, EMA20 at ₹147.3, EMA26 at ₹144.1, EMA50 at ₹136.9, EMA100 at ₹132.2, EMA200 at ₹126.2. Simple moving averages include SMA5 at ₹165.7, SMA10 at ₹149.5, SMA20 at ₹142.6, SMA30 at ₹139.5, SMA50 at ₹133.7, SMA100 at ₹125.2, SMA150 at ₹135.5, SMA200 at ₹134.5.

Support levels for Bafna Pharma are placed at First Support ₹189.56, Second Support ₹185.14, Third Support ₹182.94. Resistance levels are seen at First Resistance ₹196.18, Second Resistance ₹198.38, Third Resistance ₹202.80. Bafna Pharmaceuticals Ltd. shareholding pattern shows promoter holding at 75%, FII holding at 9.34%, DII holding at 0%, public holding at 15.66%.

Bafna Pharma Fundamentals

Market Cap

Above industry Median

413 Cr.

PE Ratio (TTM)

Above industry Median

37.20

Dividend Yield

Net Profit TTM

167.5% incr over last year

11.10

Net Profit Growth

167.5% incr over last year

11.10

PEG Ratio

Below industry Median

0.20

ROE

136.0% incr over last year

11.54

Operating Revenue TTM

150.62

Operating Revenue Growth

3.3% incr over last year

Book Value

Above industry Median

4.40

MFI

MFI strongly Overbought

82.56

RSI

RSI strongly Overbought

85.81

EPS (TTM)

-15.52

Debt to Equity

-0.71

Face Value

Operating Profit Margin Qtr.

2.86

Operating Profit Qtr.

4.24

Net Profit Qtr.

0.32

Operating Revenue Qtr.

13.13

PB Ratio

4.40

Bafna Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	42.24	38.29	35.47	34.62	39.06
Operating Expense	38.69	35.24	31.19	29.56	35.95
Operating Profit	3.55	3.05	4.28	5.07	3.11
Depreciation	1.66	1.57	1.47	1.37	0.22
Interest	1.03	0.86	0.86	0.91	0.82
Tax	-0.13	0	0	0	0
Net Profit	2.75	1.84	3.12	3.39	1.31

Bafna Pharma Technicals

Bafna Pharmaceuticals Ltd. EMA & SMA

₹174.58

-19.39 (-10.00%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹169.9

Day EMA10 ₹157.3

Day EMA12 ₹154.4

Day EMA20 ₹147.3

Day EMA26 ₹144.1

Day EMA50 ₹136.9

Day EMA100 ₹132.2

Day EMA200 ₹126.2

Bafna Pharma Support and Resistance

Resistance

First Resistance₹196.18

Second Resistance₹198.38

Third Resistance₹202.80

Support

First Support₹189.56

Second Support₹185.14

Third Support₹182.94

Technical Indicators

Day RSI85.81

Day MFI82.56

Day ADX26.26

Day Commodity Channel Index297.80

William-

Day MACD10.31

Day MACD Signal Line4.87

Day ATR8.54

Day ROC12528.30

Day ROC2147.82

Bafna Pharma Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	88.3	75	75	75	75	75
FII	0	8.5	9.3	9.3	9.3	9.3
DII	0	0	0	0	0	0
Public	11.7	16.5	15.7	15.7	15.7	15.7

Bafna Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	22.34 K	31.86 K	70.11%
Week	11.04 K	13.54 K	81.53%
1 Month	5.05 K	6.01 K	83.95%
6 Month	4.38 K	5 K	87.65%

Bafna Pharma SWOT Analysis

Strengths30

Weakness8

Opportunity0

Threats1

High DVM Mid and Small Caps (subscription)

Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield

Strong Performer, Getting Expensive (DVM)

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over 1 Year

Companies with high TTM EPS Growth

Growth Stars: Strongest Annual EPS Performers

Stocks whose current price is 20% higher than week low, and more than previous close

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Stocks gaining versus previous close, open price and RSI

New 52 week high today

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing Revenue every quarter for the past 3 quarters

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Stock gained more than 20% in one month

Highest Recovery from 52 Week Low

New 52 Week High

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Bafna Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
19 Sep, 2013	0.6	FINAL		Equity Share

Bafna Pharma Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.	Senores Pharmaceuticals Ltd.
Price (₹)	₹558.75	₹6.16	₹136.48	₹15.10	₹563.90	₹1,095
% Change	1.42%	-1.12%	4.30%	7.40%	1.25%	8.74%
Revenue TTM (₹ Cr)	-	₹83.60	₹287.68	₹176.50	₹502.55	₹649.50
Net Profit TTM (₹ Cr)	-	₹-34.95	₹14.88	₹27.81	₹57.92	₹115.38
PE TTM	-	-1.50	35.40	28.90	28.00	43.70
1 Year Return	42.87	515	7.51	66.37	-21.47	105.39
ROCE	3.56	-5.63	-	17.36	23.87	15.60

Similar Stocks

INNOVACAP

Innova Captab Ltd.

₹ 917.10

+5.41%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 73.00

-1.27%

SIGACHI

Sigachi Industries Ltd.

₹ 21.27

+0.76%

WINDLAS

Windlas Biotech Ltd.

₹ 830.00

+1.94%

VINEETLAB

Vineet Laboratories Ltd.

₹ 33.50

+0.33%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 574.00

+9.35%

ZIMLAB

Zim Laboratories Ltd.

₹ 113.05

+5.00%

MEDICO

Medico Remedies Ltd.

₹ 42.82

-1.95%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 189.00

+2.51%

LASA

Lasa Supergenerics Ltd.

₹ 7.61

-0.65%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 373.30

+0.35%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 290.05

-0.17%

ORTINGLOBE

Ortin Global Ltd.

₹ 17.93

-9.99%

BROOKS

Brooks Laboratories Ltd.

₹ 69.00

+3.51%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2110.10

+1.01%

ALPA

Alpa Laboratories Ltd.

₹ 69.80

+2.29%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 380.00

+3.04%

NECLIFE

Nectar Lifesciences Ltd.

₹ 11.60

-0.34%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 28.40

-0.18%

INDOCO

Indoco Remedies Ltd.

₹ 207.00

+3.74%

INDSWFTLAB

Ind-Swift Laboratories Ltd.

₹ 163.70

+4.44%

LINCOLN

Lincoln Pharmaceuticals Ltd.

₹ 635.50

+2.53%

PANACEABIO

Panacea Biotec Ltd.

₹ 612.00

+10.69%

FAQ's on BAFNAPH

What is the current share price of Bafna Pharmaceuticals Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Bafna Pharmaceuticals Ltd. is ₹ 174.58 on the NSE and ₹ 176.95 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Bafna Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Bafna Pharmaceuticals Ltd. is approximately ₹ 413 Cr.

What are the PE and PB ratios for Bafna Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Bafna Pharmaceuticals Ltd. is 37.2, and the Price-to-Book (PB) ratio is 4.4.

What is the 52-Week High and Low for Bafna Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Bafna Pharmaceuticals Ltd. shares was ₹ 213.36, and the lowest price was ₹ 72.01.

Who are the major shareholders of Bafna Pharmaceuticals Ltd.?

Significant shareholdings in Bafna Pharmaceuticals Ltd. typically include entities such as:

Promoter
Public
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Bafna Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Bafna Pharmaceuticals Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Bafna Pharmaceuticals Ltd.?

Bafna Pharmaceuticals Ltd. last declared a FINAL dividend of ₹ 0.6 per share for the financial period ending 2013. The record date was set as 2013-09-19, and the payment was/is scheduled around 2013-09-19. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy